Banco de Sabadell’s Teladoc Health TDOC Stock Holding History

Banco de Sabadell’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-520	Closed	-$66K	–	100
2021 Q3	$66K	Sell	520 -500	-49%	-$72.8K	0.04%	85
2021 Q2	$172K	Sell	1,020 -2,000	-66%	-$324K	0.11%	84
2021 Q1	$531K	Buy	3,020 +1,000	+50%	+$232K	0.05%	165
2020 Q4	$406K	Buy	+2,020	New	+$411K	0.04%	193

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Banco de Sabadell's TDOC Position: Q4 2021 in Review

Banco de Sabadell sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 520 shares — an estimated $66K sold.

Banco de Sabadell first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $531K in Q1 2021. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

Banco de Sabadell reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
Banco de Sabadell sold 520 Teladoc Health shares in Q4 2021, an estimated $66K.
Banco de Sabadell first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
Banco de Sabadell's Teladoc Health position peaked at $531K in Q1 2021.
729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Banco de Sabadell's 13F filing for Q4 2021, filed 14 Feb 2022.